Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Accepts healthy volunteers

Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg

ClinicalTrials.gov ID: NCT03537768

Public ClinicalTrials.gov record NCT03537768. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 3:42 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized Study of the Efficacy of Ulipristal Acetate (UPA) 30 mg, Levonorgestrel (LNG) 1.5 mg, and LNG 3.0 mg for Emergency Contraception (EC) in Women With Weight ≥ 80 kg

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The proposed research study is a Phase IIb, multi-center, single-blind, randomized study of UPA 30 mg, LNG 1.5 mg and LNG 3.0 mg to evaluate EC effectiveness in women with weight ≥ 80 kg who present within 72 hours of unprotected intercourse.

Study identification

NCT ID
NCT03537768
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Kimberly Myer
Other
Enrollment
532 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 12, 2018 (Actual)
Primary completion
Apr 20, 2022 (Actual)
Completion
Apr 20, 2022 (Actual)
Last update posted
Nov 20, 2025

2018 – 2022

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Essential Access Health Los Angeles California 30010 —
University of California, Davis Sacramento California 95817 —
University of California, San Francisco San Francisco California 94110 —
University of Colorado Denver Colorado 80045 —
University of Hawaii Honolulu Hawaii 96826 —
University of Chicago Chicago Illinois 60637 —
Johns Hopkins Bayview Medical Center Baltimore Maryland 21224 —
Planned Parenthood League of Massachusetts Boston Massachusetts 02215 —
Bellevue Hospital Center New York New York 10016 —
Columbia University New York New York 10032 —
University of Cincinnati-Holmes Hospital Cincinnati Ohio 45267 —
University Hospitals of Cleveland MacDonald Women's Hospital Cleveland Ohio 44106 —
Oregon Health Science University Portland Oregon 97239 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Pittsburgh/Magee Women's Hospital Pittsburgh Pennsylvania 15213 —
Women & Infants Hospital of Rhode Island Providence Rhode Island 02905 —
University of Utah Salt Lake City Utah 84106 —
Eastern Virginia Medical School Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03537768, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 20, 2025 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03537768 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →